BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Terzoudis S, Zavos C, Damilakis J, Neratzoulakis J, Dimitriadi DA, Roussomoustakaki M, Kouroumalis EA, Koutroubakis IE. Increased Fracture Risk Assessed by Fracture Risk Assessment Tool in Greek Patients with Crohn’s Disease. Dig Dis Sci 2013;58:216-21. [DOI: 10.1007/s10620-012-2326-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Serrano-montalbán B, Arias Á, Friginal-ruiz AB, Lucendo AJ. The Use of the Fracture Risk Assessment (FRAX®) Tool in Predicting Risk of Fractures in Patients With Inflammatory Bowel Disease: A Systematic Review. Journal of Clinical Densitometry 2017;20:180-7. [DOI: 10.1016/j.jocd.2016.08.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
2 Krela-Kaźmierczak I, Michalak M, Szymczak-Tomczak A, Czarnywojtek A, Wawrzyniak A, Łykowska-Szuber L, Stawczyk-Eder K, Dobrowolska A, Eder P. Milk and dairy product consumption in patients with inflammatory bowel disease: Helpful or harmful to bone mineral density? Nutrition 2020;79-80:110830. [PMID: 32563771 DOI: 10.1016/j.nut.2020.110830] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Vidarsdottir JB, Johannsdottir SE, Thorsdottir I, Bjornsson E, Ramel A. A cross-sectional study on nutrient intake and -status in inflammatory bowel disease patients. Nutr J 2016;15:61. [PMID: 27268004 DOI: 10.1186/s12937-016-0178-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
4 Ghersin I, Khateeb N, Katz LH, Daher S, Shamir R, Assa A. Comorbidities in adolescents with inflammatory bowel disease: findings from a population-based cohort study. Pediatr Res 2020;87:1256-62. [PMID: 31801156 DOI: 10.1038/s41390-019-0702-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Terzoudis S, Malliaraki N, Damilakis J, Dimitriadou DA, Zavos C, Koutroubakis IE. Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2016;28:814-9. [PMID: 26934527 DOI: 10.1097/MEG.0000000000000617] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
6 Terzoudis S, Zavos C, Koutroubakis IE. The bone and fat connection in inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:2207-2217. [PMID: 24983981 DOI: 10.1097/mib.0000000000000111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]